Related Experiment Video
Updated: Feb 1, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
CB2R induces a protective response for epileptic seizure via the PI3K 110α-AKT signaling pathway
Qingjun Cao1, Xueyan Liu1, Fenghua Yang1
1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
Abstract:
Epilepsy is a chronic brain disease caused by abnormal discharging in the brain, which induces momentary brain dysfunction. Cannabinoid 2 receptor (CB2R) is expressed in central nervous system (CNS) and serves an important role in the pathogenesis of CNS diseases. The aim of the present study was to explore the effects of CB2R activation on phosphoinositide 3-kinase (PI3K) 110α-protein kinase B (AKT) signaling in an astrocyte model of epilepsy. Rat CTX TNA2 astrocytes were treated with Mg free solution to establish a cell model of epilepsy and were subsequently treated with a CB2R agonist (JWH133) and antagonist (AM630). Cell cycle analysis revealed that treatment using Mg free solution inhibited cell cycle transition. JWH133 facilitated cell cycle progression while AM630 inhibited it. Western blotting results demonstrated that treatment with Mg free solution downregulated the expression of cyclin D1, cyclin E, phosphorylated Retinoblastoma (p-Rb), B-cell lymphoma 2 (Bcl-2), PI3K 110α, p-AKT and p-mammalian target of rapamycin, whereas JWH133 treatment upregulated these proteins. AM630 ameliorated the JWH133-induced upregulation of these proteins. To confirm the involvement of AKT signaling, the AKT inhibitor wortmannin was used. The results revealed that wortmannin inhibited the effect of JWH133 on p-AKT, cyclin D1, p-Rb and Bcl-2 expression. In addition, the effects of JWH133 and AM630 on PI3K 110α-AKT signaling were verified using a rat model of epilepsy. In conclusion, the present study demonstrates that CB2R activation induces astrocyte proliferation and survival via activation of the PI3K 110α-AKT signaling pathway.
Insights
Cannabinoid 2 receptor (CB2R) activation promotes astrocyte proliferation and survival in epilepsy models by activating the PI3K/AKT pathway. This finding offers potential therapeutic targets for epilepsy treatment.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Epilepsy is a chronic neurological disorder characterized by abnormal brain activity.
- Cannabinoid 2 receptor (CB2R) plays a role in central nervous system (CNS) diseases.
Purpose of the Study:
- To investigate the effect of CB2R activation on the phosphoinositide 3-kinase (PI3K) 110α-protein kinase B (AKT) signaling pathway in an astrocyte model of epilepsy.
Main Methods:
- Established an epilepsy cell model using rat CTX TNA2 astrocytes treated with Mg-free solution.
- Administered CB2R agonist (JWH133) and antagonist (AM630).
- Performed cell cycle analysis and Western blotting; validated findings in a rat epilepsy model.
Main Results:
- Mg-free solution inhibited cell cycle progression and downregulated key proteins (cyclin D1, p-Rb, PI3K 110α, p-AKT).
- JWH133 treatment reversed these effects, promoting cell cycle progression and upregulating proteins.
- AKT inhibition (wortmannin) blocked JWH133's effects, confirming AKT pathway involvement.
Conclusions:
- CB2R activation stimulates astrocyte proliferation and survival.
- This occurs through the activation of the PI3K 110α-AKT signaling pathway.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway

